Related Experiment Video
Updated: Feb 13, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Surgical Approaches to Hypertrophic Obstructive Cardiomyopathy
Zachary Solomon1, Catalina Breton1, Ethan J Rowin2
1Hypertrophic Cardiomyopathy Institute, Division of Cardiac Surgery, CardioVascular Center, Tufts Medical Center, Boston, Massachusetts.
Extended septal myectomy and alcohol septal ablation significantly improve outcomes for patients with hypertrophic obstructive cardiomyopathy. These interventions offer low mortality and complication rates, enhancing functional capacity.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) presents a significant clinical challenge, particularly regarding left ventricular outflow tract (LVOT) obstruction.
- Clinician hesitation towards invasive therapies stems from historical concerns about high morbidity and mortality rates.
Purpose of the Study:
- To review the treatment of HOCM, focusing on extended septal myectomy and alcohol septal ablation.
- To evaluate the short- and long-term outcomes, perioperative complications, and surgical tenets associated with these interventions.
Main Methods:
- Literature review of studies evaluating extended septal myectomy and alcohol septal ablation for HOCM.
- Analysis of outcomes including mortality, morbidity, LVOT pressure gradients, and functional capacity (New York Heart Association class).
Main Results:
- Both extended septal myectomy and alcohol septal ablation demonstrate significantly improved short- and long-term outcomes compared to non-intervention.
- Mortality rates associated with these procedures approach zero, with infrequent perioperative complications.
- Interventions consistently reduce LVOT pressure gradients and improve functional capacity, lowering NYHA class.
Conclusions:
- Extended septal myectomy and alcohol septal ablation are effective and safe treatments for symptomatic HOCM refractory to medical management.
- These invasive therapies should be recommended for patients experiencing persistent symptoms despite standard medical care.
- The data support improved patient outcomes and quality of life following these interventions.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management

